Cellular Reprogramming Employing Recombinant Sox2 Protein

Induced pluripotent stem (iPS) cells represent an attractive option for the derivation of patient-specific pluripotent cells for cell replacement therapies as well as disease modeling. To become clinically meaningful, safe iPS cells need to be generated exhibiting no permanent genetic modifications...

Descripción completa

Detalles Bibliográficos
Autores principales: Thier, Marc, Münst, Bernhard, Mielke, Stephanie, Edenhofer, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368608/
https://www.ncbi.nlm.nih.gov/pubmed/22693519
http://dx.doi.org/10.1155/2012/549846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368608/
https://www.ncbi.nlm.nih.gov/pubmed/22693519
http://dx.doi.org/10.1155/2012/549846

Ejemplares similares